Complexities of chromium carcinogenesis: Role of cellular response, repair and recovery mechanisms

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 533, Issue 1-2, 2003, Pages 3-36

  O'Brien, Travis J ^a   Ceryak, Susan ^a   Patierno, Steven R ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cellular response; Cr(VI); DNA damage; Hexavalent chromium; Repair

Indexed keywords

ASCORBIC ACID; CHROMIUM; CYSTEINE; GLUTATHIONE;

APOPTOSIS; CELL ACTIVITY; CELL CYCLE; CELL DAMAGE; CELL FATE; CELL GROWTH; CELL MEMBRANE; CELL REGENERATION; CROSS LINKING; CYTOTOXICITY; DNA ADDUCT; DNA DAMAGE; DNA REPLICATION; ENVIRONMENTAL FACTOR; GENETIC DAMAGE; GENOTOXICITY; HEALTH HAZARD; HUMAN; ION TRANSPORT; LUNG CARCINOGENESIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REDUCTION; REVIEW; RISK ASSESSMENT; RNA SYNTHESIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOLUBILITY;

EID: 0345708258     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.09.006     Document Type: Review

References (330)

1. Anderson R.A. Nutritional role of chromium. Sci. Total Environ. 17:1981;13-29.
2. Fishbein L. Sources, transport and alteration of metal compunds: an overview. I. Arsenic, beryllium, cadmium, chromium and nickel. Environ. Health Perspect. 40:1981;43-65.
3. P.H.S. US Department of Health and Human Services, Agency for Toxic Substances and Disease Registry Toxicological Profile for Chromium, September 2000.
4. IARC Monograph on the Evaluation of Carcinogenic Risk to Humans, Chromium, Nickel and Welding, Lyon, France, 1990.
5. Salnikow K., Zhitkovich A., Costa M. Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells. Carcinogenesis. 13:1992;2341-2346.
6. Bianchi V., Levis A.G. Review of genetic effects and mechanisms of action of chromium compounds. Sci. Total Environ. 71:1988;351-355.
7. De Flora S., Bagnasco M., Serra D., Zanacchi P. Genotoxicity of chromium compounds. A review. Mutat. Res. 238:1990;99-172.
8. De Flora S. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis. 21:2000;533-541.
9. Sugden K.D., Stearns D.M. The role of chromium(V) in the mechanism of chromate-induced oxidative DNA damage and cancer. J. Environ. Pathol. Toxicol. Oncol. 19:2000;215-230.
10. Snow E.T. Metal carcinogenesis: mechanistic implications. Pharmacol. Ther. 53:1992;31-65.
11. Singh J., Carlisle D.L., Pritchard D.E., Patierno S.R. Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). Oncol. Rep. 5:1998;1307-1318.
12. EPA Health Assessment Document for Chromium, Environmental Assessment and Crtieria Office, US Environmental Protection Agency, Research Triangle Park, NW, 1984.
13. EPA Locating and Estimating Air Emissions from Sources of Chromium, Office of Air Quality Planning and Standards, US Environmental Protection Agency, Research Triangle Park, NC, 1984.
14. EPA Health Effects Assessment for Hexavalent Chromium, Office of Emrgency and Remedial Response, US Environmental Protection Agency, Cincinnati, OH, 1984.
15. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, International Agency for Research on Cancer, Lyon, France, 1982, pp. 167-170.
16. Machle W., Gregorius F. Cancer of the respiratory system in the United States chromate-producing industry. Publ. Health Rep. 63:1948;114-127.
17. Leonard A., Lauwerys R.R. Carcinogenicity and mutagenicity of chromium. Mutat. Res. 76:1980;227-239.
18. Levy L.S., Martin P.A., Bidstrup P.L. Investigation of the potential carcinogenicity of a range of chromium containing materials on rat lung. Br. J. Ind. Med. 43:1986;243-256.
19. Yu W., Sipowicz M., Haines D., Birely L., Diwan B., Riggs C., Kasprzak K., Anderson L. Preconception urethane or chromium(III) treatment of male mice: multiple neoplastic and non-neoplastic changes in offspring. Toxicol. Appl. Pharmacol. 158:1999;161-176.
20. Cheng R., Alvord W., Powell D., Kasprzak K., Anderson L. Increased serum corticosterone and glucose in the offsrping of chromium(III)-treated male mice. Environ. Health Perspect. 110:2002;801-804.
21. Cheng R., Alvor W., Powell D., Kasprzak K., Anderson L. Microarray analysis of altered gene expression in the TM4 sertoli-like cell line exposed to chromium(III) chloride. Reprod. Toxicol. 16:2002;223-236.
22. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., Tsuchiya E. Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: an autopsy study. Br. J. Cancer. 70:1994;160-166.
23. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., Tsuchiya E. "Hot spots" of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res. 54:1994;2342-2346.
24. Sheehan P.J., Meyer D.M., Sauer M.M., Paustenbach D.J. Assessment of the human health risks posed by exposure to chromium-contaminated soils. J. Toxicol. Environ. Health. 32:1991;161-201.
25. Arslan P., Beltrame M., Tomasi A. Intracellular chromium reduction. Biochim. Biophys. Acta. 931:1987;10-15.
26. Buttner B., Beyersmann D. Modification of the erythrocyte anion carrier by chromate. Xenobiotica. 15:1985;735-741.
27. Mikalsen A., Alexander J., Ryberg D. Microsomal metabolism of hexavalent chromium. Inhibitory effect of oxygen and involvement of cytochrome P-450. Chem. Biol. Interact. 69:1989;175-192.
28. Mikalsen A., Alexander J., Andersen R.A., Daae H.L. Reduction of hexavalent chromium in a reconstituted system of cytochrome P-450 and cytochrome b5. Chem. Biol. Interact. 71:1989;213-221.
29. Mikalsen A., Alexander J., Wallin H., Ingelman-Sundberg M., Andersen R.A. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes. Carcinogenesis. 12:1991;825-831.
30. Ryberg D., Alexander J. Inhibitory action of hexavalent chromium (Cr(VI)) on the mitochondrial respiration and a possible coupling to the reduction of Cr(VI). Biochem. Pharmacol. 33:1984;2461-2466.
31. Ryberg D., Alexander J. Mechanisms of chromium toxicity in mitochondria. Chem. Biol. Interact. 75:1990;141-151.
32. Shi X.L., Dalal N.S. Chromium(V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium(VI). Biochem. Biophys. Res. Commun. 163:1989;627-634.
33. Banks R.B., Cooke R.T. Jr. Chromate reduction by rabbit liver aldehyde oxidase. Biochem. Biophys. Res. Commun. 137:1986;8-14.
34. Kawanishi S., Inoue S., Sano S. Mechanism of DNA cleavage induced by sodium chromate(VI) in the presence of hydrogen peroxide. J. Biol. Chem. 261:1986;5952-5958.
35. Pattison D.I., Davies M.J., Levina A., Dixon N.E., Lay P.A. Chromium(VI) reduction by catechol(amine)s results in DNA cleavage in vitro: relevance to chromium genotoxicity. Chem. Res. Toxicol. 14:2001;500-510.
36. DeFlora S., Morelli A., Basso C., Romano M., Serra D., DeFlora A. Pominent role of DT-diaphorase as a cellular mechanim reducing chromium(VI) and reverting its mutagenicity. Cancer Res. 45:1985;3188-3196.
37. De Flora S., Camoirano A., Bagnasco M., Bennicelli C., Corbett G.E., Kerger B.D. Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis. 18:1997;531-537.
38. Quievryn G., Peterson E., Messer J., Zhitkovich A. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry. 42:2003;1062-1070.
39. Borges K.M., Wetterhahn K.E. Chromium cross-links glutathione and cysteine to DNA. Carcinogenesis. 10:1989;2165-2168.
40. Standeven A.M., Wetterhahn K.E. Is there a role for reactive oxygen species in the mechanism of chromium(VI) carcinogenesis? Chem. Res. Toxicol. 4:1991;616-625.
41. De Flora S., Bennicelli C., Camoirano A., Serra D., Hochstein P. Influence of DT diaphorase on the mutagenicity of organic and inorganic compounds. Carcinogenesis. 9:1988;611-617.
42. Rossi S.C., Wetterhahn K.E. Chromium(V) is produced upon reduction of chromate by mitochondrial electron transport chain complexes. Carcinogenesis. 10:1989;913-920.
43. Rossi S.C., Gorman N., Wetterhahn K.E. Mitochondrial reduction of the carcinogen chromate: formation of chromium(V). Chem. Res. Toxicol. 1:1988;101-107.
44. Tomaszewski K.E., Agarwal D.K., Melnick R.L. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Carcinogenesis. 7:1986;1871-1876.
45. Stearns D.M., Kennedy L.J., Courtney K.D., Giangrande P.H., Phieffer L.S., Wetterhahn K.E. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry. 34:1995;910-919.
46. Stearns D.M., Courtney K.D., Giangrande P.H., Phieffer L.S., Wetterhahn K.E. Chromium(VI) reduction by ascorbate: role of reactive intermediates in DNA damage in vitro. Environ. Health Perspect. 102(Suppl. 3):1994;21-25.
47. Stearns D.M., Wetterhahn K.E. Reaction of chromium(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals. Chem. Res. Toxicol. 7:1994;219-230.
48. Jacob R.A., Sotoudeh G. Vitamin C function and status in chronic disease. Nutr. Clin. Care. 5:2002;66-74.
49. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem. 269:1994;9397-9400.
50. Standeven A.M., Wetterhahn K.E. Ascorbate is the principal reductant of chromium(VI) in rat liver and kidney ultrafiltrates. Carcinogenesis. 12:1991;1733-1737.
51. Standeven A.M., Wetterhahn K.E. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis. 13:1992;1319-1324.
52. O'Brien T., Mandel H.G., Pritchard D.E., Patierno S.R. Critical role of chromium (Cr)-DNA interactions in the Formation of Cr-induced polymerase arresting lesions. Biochemistry. 41:2002;12529-12537.
53. Casarett and Doull's Casarett and Doull's Toxicology, The Basic Science of Poisons, Pergamon Press, New York, NY.
54. Wetterhahn K.E., Hamilton J.W., Aiyar J., Borges K.M., Floyd R. Mechanism of chromium(VI) carcinogenesis. Reactive intermediates and effect on gene expression. Biol. Trace Elem. Res. 21:1989;405-411.
55. Aiyar J., Berkovits H.J., Floyd R.A., Wetterhahn K.E. Reaction of chromium(VI) with hydrogen peroxide in the presence of glutathione: reactive intermediates and resulting DNA damage. Chem. Res. Toxicol. 3:1990;595-603.
56. Aiyar J., Berkovits H.J., Floyd R.A., Wetterhahn K.E. Reaction of chromium(VI) with glutathione or with hydrogen peroxide: identification of reactive intermediates and their role in chromium(VI)-induced DNA damage. Environ. Health Perspect. 92:1991;53-62.
57. Borges K.M., Boswell J.S., Liebross R.H., Wetterhahn K.E. Activation of chromium(VI) by thiols results in chromium(V) formation, chromium binding to DNA and altered DNA conformation. Carcinogenesis. 12:1991;551-561.
58. Zhitkovich A., Shrager S., Messer J. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr-DNA adducts in the absence of oxidative DNA damage. Chem. Res. Toxicol. 13:2000;1114-1124.
59. Zhitkovich A., Quievryn G., Messer J., Motylevich Z. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI). Environ. Health Perspect. 110(Suppl. 5):2002;729-731.
60. Quievryn G., Goulart M., Messer J., Zhitkovich A. Reduction of Cr(VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates. Mol. Cell Biochem. 222:2001;107-118.
61. Voitkun V., Zhitkovich A., Costa M. Complexing of amino acids to DNA by chromate in intact cells. Environ. Health Perspect. 102(Suppl. 3):1994;251-255.
62. Voitkun V., Zhitkovich A., Costa M. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucl. Acids Res. 26:1998;2024-2030.
63. Zhitkovich A., Voitkun V., Costa M. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group. Biochemistry. 35:1996;7275-7282.
64. Zhitkovich A., Voitkun V., Costa M. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis. 16:1995;907-913.
65. Zhitkovich A., Song Y., Quievryn G., Voitkun V. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry. 40:2001;549-560.
66. Chen J., Thilly W.G. Use of denaturing-gradient gel electrophoresis to study chromium-induced point mutations in human cells. Environ. Health Perspect. 102(Suppl. 3):1994;227-229.
67. Chen J., Thilly W.G. Mutational spectrum of chromium(VI) in human cells. Mutat. Res. 323:1994;21-27.
68. Yang J.L., Hsieh Y.C., Wu C.W., Lee T.C. Mutational specificity of chromium(VI) compounds in the hprt locus of Chinese hamster ovary-K1 cells. Carcinogenesis. 13:1992;2053-2057.
69. Elias Z., Schneider O., Aubry F., Daniere M.C., Poirot O. Sister chromatid exchanges in Chinese hamster V79 cells treated with the trivalent chromium compounds chromic chloride and chromic oxide. Carcinogenesis. 4:1983;605-611.
70. Bianchi V., Celotti L., Lanfranchi G., Majone F., Marin G., Montaldi A., Sponza G., Tamino G., Venier P., Zantedeschi A., Levis A.G. Genetic effects of chromium compounds. Mutat. Res. 117:1983;279-300.
71. Venier P., Montaldi A., Majone F., Bianchi V., Levis A.G. Cytotoxic, mutagenic and clastogenic effects of industrial chromium compounds. Carcinogenesis. 3:1982;1331-1338.
72. Sen P., Costa M. Incidence and localization of sister chromatid exchanges induced by nickel and chromium compounds. Carcinogenesis. 7:1986;1527-1533.
73. 3) in electroplating factories. Carcinogenesis. 3:1982;1011-1016.
74. Sugiyama M., Tsuzuki K., Hidaka T., Ogura R., Yamamoto M. Reduction of chromium(VI) in Chinese hamster V-79 cells. Biol. Trace Elem. Res. 30:1991;1-8.
75. Sugiyama M. Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free Rad. Biol. Med. 12:1992;397-407.
76. Wise J.P. Sr., Stearns D.M., Wetterhahn K.E., Patierno S.R. Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis. Carcinogenesis. 15:1994;2249-2254.
77. Bianchi V., Dal Toso R., Debetto P., Levis A.G., Luciani S., Majone F., Tamino G. Mechanisms of chromium toxicity in mammalian cell cultures. Toxicology. 17:1980;219-224.
78. Wise J.P., Orenstein J.M., Patierno S.R. Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake. Carcinogenesis. 14:1993;429-434.
79. Tsapakos M.J., Wetterhahn K.E. The interaction of chromium with nucleic acids. Chem. Biol. Interact. 46:1983;265-277.
80. Shi X.L., Dalal N.S. Evidence for a Fenton-type mechanism for the generation of ·OH radicals in the reduction of Cr(VI) in cellular media. Arch. Biochem. Biophys. 281:1990;90-95.
81. Shi X., Mao Y., Knapton A.D., Ding M., Rojanasakul Y., Gannett P.M., Dalal N., Liu K. Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: role of a Cr(IV)-mediated Fenton-like reaction. Carcinogenesis. 15:1994;2475-2478.
82. Lin X., Zhuang Z., Costa M. Analysis of residual amino acid-DNA crosslinks induced in intact cells by nickel and chromium compounds. Carcinogenesis. 13:1992;1763-1768.
83. Miller C.A. III, Costa M. Characterization of DNA-protein complexes induced in intact cells by the carcinogen chromate. Mol. Carcinog. 1:1988;125-133.
84. Miller C.A. III, Cohen M.D., Costa M. Complexing of actin and other nuclear proteins to DNA by cis-diamminedichloroplatinum(II) and chromium compounds. Carcinogenesis. 12:1991;269-276.
85. Zhitkovich A., Costa M. A simple, sensitive assay to detect DNA-protein crosslinks in intact cells and in vivo. Carcinogenesis. 13:1992;1485-1489.
86. Krupa R., Stanczak M., Walter Z. Chromium incorporated in RNA and DNA. Z. Naturforsch. [C]. 57:2002;951-953.
87. Tamino G., Peretta L., Levis A.G. Effects of the trivalent and hexavalent chromium on the physicochemical properties of mammalian cell nucleic acids and synthetic polynucleotides. Chem. Biol. Interact. 37:1981;309-319.
88. Wolf T., Kasemann R., Ottenwalder H. Molecular interaction of different chromium species with nucleotides and nucleic acids. Carcinogenesis. 10:1989;655-659.
89. O'Brien T., Xu J., Patierno S.R. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest. Mol. Cell. Biochem. 222:2001;173-182.
90. Quievryn G., Messer J., Zhitkovich A. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells. Biochemistry. 41:2002;3156-3167.
91. Sugden K.D., Wetterhahn K.E. EPR evidence for chromium(V) binding to phosphate and pyrophosphate: implications for chromium(V)-DNA interactions. Inorg. Chem. 35:1996;3727-3728.
92. Bose R.N., Fonkeng B.S., Moghaddas S., Stroup D. Mechanisms of DNA damage by chromium(V) carcinogens. Nucl. Acids Res. 26:1998;1588-1596.
93. Gulanowski B., Swiatek J., Kozlowski H. Impact of chromium ions on nucleoside triphosphates and nucleic acids. J. Inorg. Biochem. 48:1992;289-298.
94. Arakawa H., Ahmad R., Naoui M., Tajmir-Riahi H.A. A comparative study of calf thymus DNA binding to Cr(III) and Cr(VI) ions. Evidence for the guanine N-7-chromium-phosphate chelate formation. J. Biol. Chem. 275:2000;10150-10153.
95. Bridgewater L.C., Manning F.C., Woo E.S., Patierno S.R. DNA polymerase arrest by adducted trivalent chromium. Mol. Carcinog. 9:1994;122-133.
96. Bridgewater L.C., Manning F.C., Patierno S.R. Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking. Carcinogenesis. 15:1994;2421-2427.
97. Casadevall M., Kortenkamp A. The formation of both apurinic/apyrimidinic sites and single-strand breaks by chromate and glutathione arises from attack by the same single reactive species and is dependent on molecular oxygen. Carcinogenesis. 16:1995;805-809.
98. Casadevall M., da Cruz Fresco P., Kortenkamp A. Chromium(VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites. Chem. Biol. Interact. 123:1999;117-132.
99. Singh J., McLean J.A., Pritchard D.E., Montaser A., Patierno S.R. Sensitive quantitation of chromium-DNA adducts by inductively coupled plasma mass spectrometry with a direct injection high-efficiency nebulizer. Toxicol. Sci. 46:1998;260-265.
100. Snow E.T., Xu L.S. Chromium(III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication in vitro. Biochemistry. 30:1991;11238-11245.
101. Tsapakos M.J., Hampton T.H., Wetterhahn K.E. Chromium(VI)-induced DNA lesions and chromium distribution in rat kidney, liver, and lung. Cancer Res. 43:1983;5662-5667.
102. Strauss J.K., Maher L.J. III DNA bending by asymmetric phosphate neutralization. Science. 266:1994;1829-1834.
103. Rodriguez H., Holmquist G.P., D'Agostino R. Jr., Keller J., Akman S.A. Metal ion-dependent hydrogen peroxide-induced DNA damage is more sequence specific than metal specific. Cancer Res. 57:1997;2394-2403.
104. Sugden K.D., Wetterhahn K.E. Direct and hydrogen peroxide-induced chromium(V) oxidation of deoxyribose in single-stranded and double-stranded calf thymus DNA. Chem. Res. Toxicol. 10:1997;1397-1406.
105. Sugden K.D., Campo C.K., Martin B.D. Direct oxidation of guanine and 7,8-dihydro-8-oxoguanine in DNA by a high-valent chromium complex: a possible mechanism for chromate genotoxicity. Chem. Res. Toxicol. 14:2001;1315-1322.
106. Sugden K.D., Martin B.D. Guanine and 7,8-dihydro-8-oxo-guanine-specific oxidation in DNA by chromium(V). Environ. Health Perspect. 110(Suppl. 5):2002;725-728.
107. Bose R.N., Moghaddas S., Mazzer P.A., Dudones L.P., Joudah L., Stroup D. Oxidative damage of DNA by chromium(V) complexes: relative importance of base versus sugar oxidation. Nucl. Acids Res. 27:1999;2219-2226.
108. Rodriguez H., Akman S.A. Mapping oxidative DNA damage at nucleotide level. Free Rad. Res. 29:1998;499-510.
109. L. Joudah, S. Moghaddas, R.N. Bose, DNA oxidation by peroxo-chromium(V) species: oxidation of guanosine to guanidinohydantoin, Chem. Commun. (Camb.) (2002) 1742-1743.
110. Martin B.D., Schoenhard J.A., Sugden K.D. Hypervalent chromium mimics reactive oxygen species as measured by the oxidant-sensitive dyes 2′,7′-dichlorofluorescin and dihydrorhodamine. Chem. Res. Toxicol. 11:1998;1402-1410.
111. Simukova N.A., Budowsky E.I. Conversion of non-covalent interactions in nucleoproteins into covalent bonds: UV-induced formation of polynucleotide- protein crosslinks in bacteriophage Sd virions. FEBS Lett. 38:1974;299-303.
112. Filipski J., Kohn K.W., Bonner W.M. Differential crosslinking of histones and non-histones in nuclei by cis-Pt(II). FEBS Lett. 152:1983;105-108.
113. Fornace A.J. Jr., Seres D.S., Lechner J.F., Harris C.C. DNA-protein cross-linking by chromium salts. Chem. Biol. Interact. 36:1981;345-354.
114. Miller C.A. III, Costa M. Analysis of proteins cross-linked to DNA after treatment of cells with formaldehyde, chromate, and cis- diamminedichloroplatinum(II). Mol. Toxicol. 2:1989;11-26.
115. Xu J., Manning F.C., Patierno S.R. Preferential formation and repair of chromium-induced DNA adducts and DNA - protein crosslinks in nuclear matrix DNA. Carcinogenesis. 15:1994;1443-1450.
116. Toniolo P., Zhitkovich A., Costa M. Development and utilization of a new simple assay for DNA-protein crosslinks as a biomarker of exposure to welding fumes. Int. Arch. Occup. Environ. Health. 65:1993;S87-S89.
117. Cupo D.Y., Wetterhahn K.E. Binding of chromium to chromatin and DNA from liver and kidney of rats treated with sodium dichromate and chromium(III) chloride in vivo. Cancer Res. 45:1985;1146-1151.
118. Mattagajasingh S.N., Misra H.P. Mechanisms of the carcinogenic chromium(VI)-induced DNA-protein cross-linking and their characterization in cultured intact human cells. J. Biol. Chem. 271:1996;33550-33560.
119. Hneihen A.S., Standeven A.M., Wetterhahn K.E. Differential binding of chromium(VI) and chromium(III) complexes to salmon sperm nuclei and nuclear DNA and isolated calf thymus DNA. Carcinogenesis. 14:1993;1795-1803.
120. Kortenkamp A., O'Brien P., Beyersmann D. The reduction of chromate is a prerequisite of chromium binding to cell nuclei. Carcinogenesis. 12:1991;1143-1144.
121. Christie N.T., Cantoni O., Evans R.M., Meyn R.E., Costa M. Use of mammalian DNA repair-deficient mutants to assess the effects of toxic metal compounds on DNA. Biochem. Pharmacol. 33:1984;1661-1670.
122. Tsapakos M.J., Hampton T.H., Sinclair P.R., Sinclair J.F., Bement W.J., Wetterhahn K.E. The carcinogen chromate causes DNA damage and inhibits drug-mediated induction of porphyrin accumulation and glucuronidation in chick embryo hepatocytes. Carcinogenesis. 4:1983;959-966.
123. Hamilton J.W., Wetterhahn K.E. Chromium(VI)-induced DNA damage in chick embryo liver and blood cells in vivo. Carcinogenesis. 7:1986;2085-2088.
124. Ueno S., Kashimoto T., Susa N., Furukawa Y., Ishii M., Yokoi K., Yasuno M., Sasaki Y.F., Ueda J., Nishimura Y., Sugiyama M. Detection of dichromate (VI)-induced DNA strand breaks and formation of paramagnetic chromium in multiple mouse organs. Toxicol. Appl. Pharmacol. 170:2001;56-62.
125. Werfel U., Langen V., Eickhoff I., Schoonbrood J., Vahrenholz C., Brauksiepe A., Popp W., Norpoth K. Elevated DNA single-strand breakage frequencies in lymphocytes of welders exposed to chromium and nickel. Carcinogenesis. 19:1998;413-418.
126. Ha L., Ceryak S., Patierno S.R. Chromium (VI) activates ATM: requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem. 278:2003;17885-17894.
127. O'Brien T.J., Fornsaglio J.L., Ceryak S., Patierno S.R. Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae. DNA Repair (Amst.). 1:2002;617-627.
128. Sugiyama M., Ando A., Nakao K., Ueta H., Hidaka T., Ogura R. Influence of Vitamin B2 on formation of chromium(V), alkali-labile sites, and lethality of sodium chromate(VI) in Chinese hamster V-79 cells. Cancer Res. 49:1989;6180-6184.
129. Sugiyama M., Tsuzuki K., Ogura R. Effect of ascorbic acid on DNA damage, cytotoxicity, glutathione reductase, and formation of paramagnetic chromium in Chinese hamster V-79 cells treated with sodium chromate(VI). J. Biol. Chem. 266:1991;3383-3386.
130. Sugiyama M., Tsuzuki K., Haramaki N. Influence of o-phenanthroline on DNA single-strand breaks, alkali-labile sites, glutathione reductase, and formation of chromium(V) in Chinese hamster V-79 cells treated with sodium chromate(VI). Arch. Biochem. Biophys. 305:1993;261-266.
131. Blasiak J., Kowalik J. A comparison of the in vitro genotoxicity of tri- and hexa-valent chromium. Mutat. Res. 469:2000;135-145.
132. Dana Devi K., Rozati R., Saleha Banu B., Jamil K., Grover P. In vivo genotoxic effect of potassium dichromate in mice leukocytes using comet assay. Food Chem. Toxicol. 39:2001;859-865.
133. Koppen G., Verschaeve L. The alkaline comet test on plant cells: a new genotoxicity test for DNA strand breaks in Vicia faba root cells. Mutat. Res. 360:1996;193-200.
134. Martin F.L., Cole K.J., Orme M.H., Grover P.L., Phillips D.H., Venitt S. The DNA repair inhibitors hydroxyurea and cytosine arabinoside enhance the sensitivity of the alkaline single-cell gel electrophoresis ('comet') assay in metabolically-competent MCL-5 cells. Mutat. Res. 445:1999;21-43.
135. Trzeciak A., Kowalik J., Malecka-Panas E., Drzewoski J., Wojewodzka M., Iwanenko T., Blasiak J. Genotoxicity of chromium in human gastric mucosa cells and peripheral blood lymphocytes evaluated by the single cell gel electrophoresis (Comet assay). Med. Sci. Monit. 6:2000;24-29.
136. Tsou T.C., Chen C.L., Liu T.Y., Yang J.L. Induction of 8-hydroxydeoxyguanosine in DNA by chromium(III) plus hydrogen peroxide and its prevention by scavengers. Carcinogenesis. 17:1996;103-108.
137. Ueno S., Sugiyama M., Susa N., Furukawa Y. Effect of dimethylthiourea on chromium (VI)-induced DNA single-strand breaks in Chinese hamster V-79 cells. Mutat. Res. 346:1995;247-253.
138. Kortenkamp A., Oetken G., Beyersmann D. The DNA cleavage induced by a chromium(V) complex and by chromate and glutathione is mediated by activated oxygen species. Mutat. Res. 232:1990;155-161.
139. Kortenkamp A., Casadevall M., Faux S.P., Jenner A., Shayer R.O., Woodbridge N., O'Brien P. A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium(VI) by glutathione. Arch. Biochem. Biophys. 329:1996;199-207.
140. Bagchi D., Stohs S.J., Downs B.W., Bagchi M., Preuss H.G. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology. 180:2002;5-22.
141. Balansky R.M., D'Agostini F., Izzotti A., De Flora S. Less than additive interaction between cigarette smoke and chromium(VI) in inducing clastogenic damage in rodents. Carcinogenesis. 21:2000;1677-1682.
142. Benova D., Hadjidekova V., Hristova R., Nikolova T., Boulanova M., Georgieva I., Grigorova M., Popov T., Panev T., Georgieva R., Natarajan A.T., Darroudi F., Nilsson R. Cytogenetic effects of hexavalent chromium in Bulgarian chromium platers. Mutat. Res. 514:2002;29-38.
143. Blankenship L.J., Carlisle D.L., Wise J.P., Orenstein J.M., Dye L.E. III, Patierno S.R. Induction of apoptotic cell death by particulate lead chromate: differential effects of Vitamins C and E on genotoxicity and survival. Toxicol. Appl. Pharmacol. 146:1997;270-280.
144. Lamson D.S., Plaza S.M. The safety and efficacy of high-dose chromium. Altern. Med. Rev. 7:2002;218-235.
145. Seoane A.I., Dulout F.N. Genotoxic ability of cadmium, chromium and nickel salts studied by kinetochore staining in the cytokinesis-blocked micronucleus assay. Mutat. Res. 490:2001;99-106.
146. Stearns D.M., Wise J.P. Sr., Patierno S.R., Wetterhahn K.E. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 9:1995;1643-1648.
147. Sugiyama M., Lin X.H., Costa M. Protective effect of Vitamin E against chromosomal aberrations and mutation induced by sodium chromate in Chinese hamster V79 cells. Mutat. Res. 260:1991;19-23.
148. Sugiyama M., Tsuzuki K., Lin X., Costa M. Potentiation of sodium chromate(VI)-induced chromosomal aberrations and mutation by Vitamin B2 in Chinese hamster V79 cells. Mutat. Res. 283:1992;211-214.
149. Wise J.P. Sr., Wise S.S., Little J.E. The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells. Mutat. Res. 517:2002;221-229.
150. Hirose T., Kondo K., Takahashi Y., Ishikura H., Fujino H., Tsuyuguchi M., Hashimoto M., Yokose T., Mukai K., Kodama T., Monden Y. Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol. Carcinog. 33:2002;172-180.
151. Lloyd D.R., Phillips D.H., Carmichael P.L. Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack. Chem. Res. Toxicol. 10:1997;393-400.
152. Singh J., Bridgewater L.C., Patierno S.R. Differential sensitivity of chromium-mediated DNA interstrand crosslinks and DNA-protein crosslinks to disruption by alkali and EDTA. Toxicol. Sci. 45:1998;72-76.
153. Bridgewater L.C., Manning F.C., Patierno S.R. Arrest of replication by mammalian DNA polymerases alpha and beta caused by chromium-DNA lesions. Mol. Carcinog. 23:1998;201-206.
154. Tsou T.C., Lai H.J., Yang J.L. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by chromium(VI) reduction with ascorbate. Chem. Res. Toxicol. 12:1999;1002-1009.
155. Tsou T.C., Lin R.J., Yang J.L. Mutational spectrum induced by chromium(III) in shuttle vectors replicated in human cells: relationship to Cr(III)-DNA interactions. Chem. Res. Toxicol. 10:1997;962-970.
156. Xu J., Bubley G.J., Detrick B., Blankenship L.J., Patierno S.R. Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest. Carcinogenesis. 17:1996;1511-1517.
157. Bauer G.B., Povirk L.F. Specificity and kinetics of interstrand and intrastrand bifunctional alkylation by nitrogen mustards at a G-G-C sequence. Nucl. Acids Res. 25:1997;1211-1218.
158. Tsou T.C., Yang J.L. Formation of reactive oxygen species and DNA strand breakage during interaction of chromium(III) and hydrogen peroxide in vitro: evidence for a chromium(III)-mediated Fenton-like reaction. Chem. Biol. Interact. 102:1996;133-153.
159. Kortenkamp A., Casadevall M., Da Cruz Fresco P. The reductive conversion of the carcinogen chromium(VI) and its role in the formation of DNA lesions. Ann. Clin. Lab. Sci. 26:1996;160-175.
160. Misra M., Alcedo J.A., Wetterhahn K.E. Two pathways for chromium(VI)-induced DNA damage in 14 day chick embryos: Cr-DNA binding in liver and 8-oxo-2′-deoxyguanosine in red blood cells. Carcinogenesis. 15:1994;2911-2917.
161. Aiyar J., Borges K.M., Floyd R.A., Wetterhahn K.E. Toxicol. Environ. Chem. 22:1989;135-148.
162. Kadiiska M.B., Xiang Q.H., Mason R.P. In vivo free radical generation by chromium(VI): an electron spin resonance spin-trapping investigation. Chem. Res. Toxicol. 7:1994;800-805.
163. Dubrovskaya V.A., Wetterhahn K.E. Effects of Cr(VI) on the expression of the oxidative stress genes in human lung cells. Carcinogenesis. 19:1998;1401-1407.
164. Sugiyama M., Tsuzuki K., Haramaki N. DNA single-strand breaks and cytotoxicity induced by sodium chromate(VI) in hydrogen peroxide-resistant cell lines. Mutat. Res. 299:1993;95-102.
165. Ueno S., Susa N., Furukawa Y., Aikawa K., Itagaki I., Komiyama T., Takashima Y. The relationship between the development of toxicity and lipid peroxidation induced by chromium compounds in rats. Kitasato Arch. Exp. Med. 61:1988;137-147.
166. Susa N., Ueno S., Furukawa Y., Sugiyama M. Protective effect of deferoxamine on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Arch. Toxicol. 71:1997;345-350.
167. Susa N., Ueno S., Furukawa Y., Sugiyama M. Protective effect of Vitamin E on chromium(VI)-induced cytotoxicity and lipid peroxidation in primary cultures of rat hepatocytes. Arch. Toxicol. 71:1996;20-24.
168. Susa N., Ueno S., Furukawa Y., Ueda J., Sugiyama M. Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol Appl. Pharmacol. 144:1997;377-384.
169. Carlisle D.L., Pritchard D.E., Singh J., Owens B.M., Blankenship L.J., Orenstein J.M., Patierno S.R. Apoptosis and P53 induction in human lung fibroblasts exposed to chromium(VI): effect of ascorbate and tocopherol. Toxicol. Sci. 55:2000;60-68.
170. Ricci J.E., Gottlieb R.A., Green D.R. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell Biol. 160:2003;65-75.
171. Newmeyer D.D., Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell. 112:2003;481-490.
172. Jackson A.L., Loeb L.A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res. 477:2001;7-21.
173. Ye J., Shi X. Gene expression profile in response to chromium-induced cell stress in A549 cells. Mol. Cell. Biochem. 222:2001;189-197.
174. Izzotti A., Cartiglia C., Balansky R., D'Agostini F., Longobardi M., De Flora S. Selective induction of gene expression in rat lung by hexavalent chromium. Mol. Carcinog. 35:2002;75-84.
175. D'Agostini F., Izzotti A., Bennicelli C., Camoirano A., Tampa E., De Flora S. Induction of apoptosis in the lung but not in the liver of rats receiving intra-tracheal instillations of chromium(VI). Carcinogenesis. 23:2002;587-593.
176. da Cruz Fresco P., Kortenkamp A. The formation of DNA cleaving species during the reduction of chromate by ascorbate. Carcinogenesis. 15:1994;1773-1778.
177. Liu S., Dixon K. Induction of mutagenic DNA damage by chromium(VI) and glutathione. Environ. Mol. Mutagen. 28:1996;71-79.
178. Liu S., Medvedovic M., Dixon K. Mutational specificity in a shuttle vector replicating in chromium(VI)-treated mammalian cells. Environ. Mol. Mutagen. 33:1999;313-319.
179. Liu K.J., Shi X., Dalal N.S. Synthesis of Cr(IV)-GSH, its identification and its free hydroxyl radical generation: a model compound for Cr(VI) carcinogenicity. Biochem. Biophys. Res. Commun. 235:1997;54-58.
180. Cordeiro-Stone M., Zaritskaya L.S., Price L.K., Kaufmann W.K. Replication fork bypass of a pyrimidine dimer blocking leading strand DNA synthesis. J. Biol. Chem. 272:1997;13945-13954.
181. Michel B. Replication fork arrest and DNA recombination. Trends Biochem. Sci. 25:2000;173-178.
182. Ljungman M., Zhang F. Blockage of RNA polymerase as a possible trigger for UV light-induced apoptosis. Oncogene. 13:1996;823-831.
183. Yu S.L., Johnson R.E., Prakash S., Prakash L. Requirement of DNA polymerase eta for error-free bypass of UV-induced CC and TC photoproducts. Mol. Cell Biol. 21:2001;185-188.
184. Nikolaishvili-Feinberg N., Cordeiro-Stone M. Bypass replication in vitro of UV-induced photoproducts blocking leading or lagging strand synthesis. Biochemistry. 40:2001;15215-15223.
185. Zhang H., Siede W. UV-induced T → C transition at a TT photoproduct site is dependent on Saccharomyces cerevisiae polymerase eta in vivo. Nucl. Acids Res. 30:2002;1262-1267.
186. Levis A.G., Bianchi V., Tamino G., Pegoraro B. Cytotoxic effects of hexavalent and trivalent chromium on mammalian cells in vitro. Br. J. Cancer. 37:1978;386-396.
187. Bianchi V., Debetto P., Zantedeschi A., Levis A.G. Effects of hexavalent chromium on the adenylate pool of hamster fibroblasts. Toxicology. 25:1982;19-30.
188. Bianchi V. Nucleotide pool unbalance induced in cultured cells by treatments with different chemicals. Toxicology. 25:1982;13-18.
189. Piette J., Hearst J. Sites of termination of in vitro DNA synthesis on psoralen phototreated single-stranded templates. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 48:1985;381-388.
190. Piette J.G., Hearst J.E. Termination sites of the in vitro nick-translation reaction on DNA that had photoreacted with psoralen. Proc. Natl. Acad. Sci. U.S.A. 80:1983;5540-5544.
191. Braithwaite E., Wu X., Wang Z. Repair of DNA lesions: mechanisms and relative repair efficiencies. Mutat. Res. 424:1999;207-219.
192. Denissenko M.F., Cahill J., Koudriakova T.B., Gerber N., Pfeifer G.P. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems. Mutat. Res. 425:1999;205-211.
193. Van Houten B., Cheng S., Chen Y. Measuring gene-specific nucleotide excision repair in human cells using quantitative amplification of long targets from nanogram quantities of DNA. Mutat. Res. 460:2000;81-94.
194. Wagner J., Kamiya H., Fuchs R.P. Leading versus lagging strand mutagenesis induced by 7,8-dihydro-8-oxo-2′-deoxyguanosine in Escherichia coli. J. Mol. Biol. 265:1997;302-309.
195. Kalinowski D.P., Illenye S., Van Houten B. Analysis of DNA damage and repair in murine leukemia L1210 cells using a quantitative polymerase chain reaction assay. Nucl. Acids Res. 20:1992;3485-3494.
196. Oleykowski C.A., Mayernik J.A., Lim S.E., Groopman J.D., Grossman L., Wogan G.N., Yeung A.T. Repair of aflatoxin B1 DNA adducts by the UvrABC endonuclease of Escherichia coli. J. Biol. Chem. 268:1993;7990-8002.
197. Snow E.T., Xu L.S. Effects of chromium(III) on DNA replication in vitro. Biol. Trace Elem. Res. 21:1989;61-71.
198. Singh J., Su L., Snow E.T. Replication across O6-methylguanine by human DNA polymerase beta in vitro. Insights into the futile cytotoxic repair and mutagenesis of O6-methylguanine. J. Biol. Chem. 271:1996;28391-28398.
199. Snow E.T. Effects of chromium on DNA replication in vitro. Environ. Health Perspect. 102(Suppl. 3):1994;41-44.
200. Sirover M.A., Loeb L.A. Infidelity of DNA synthesis in vitro: screening for potential metal mutagens or carcinogens. Science. 194:1976;1434-1436.
201. Tkeshelashvili L.K., Shearman C.W., Zakour R.A., Koplitz R.M., Loeb L.A. Effects of arsenic, selenium, and chromium on the fidelity of DNA synthesis. Cancer Res. 40:1980;2455-2460.
202. Okada S., Ohba H., Taniyama M. Alterations in ribonucleic acid synthesis by chromium(III). J. Inorg. Biochem. 15:1981;223-231.
203. Manning F.C., Blankenship L.J., Wise J.P., Xu J., Bridgewater L.C., Patierno S.R. Induction of internucleosomal DNA fragmentation by carcinogenic chromate: relationship to DNA damage, genotoxicity, and inhibition of macromolecular synthesis. Environ. Health Perspect. 102(Suppl. 3):1994;159-167.
204. Manning F.C., Xu J., Patierno S.R. Transcriptional inhibition by carcinogenic chromate: relationship to DNA damage. Mol. Carcinog. 6:1992;270-279.
205. Hamilton J.W., Wetterhahn K.E. Differential effects of chromium(VI) on constitutive and inducible gene expression in chick embryo liver in vivo and correlation with chromium(VI)-induced DNA damage. Mol. Carcinog. 2:1989;274-286.
206. Alcedo J.A., Misra M., Hamilton J.W., Wetterhahn K.E. The genotoxic carcinogen chromium(VI) alters the metal-inducible expression but not the basal expression of the metallothionein gene in vivo. Carcinogenesis. 15:1994;1089-1092.
207. Xu J., Manning F.C.R., O'Brien T.J., Ceryak S., Patierno S.R. Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest. Mol. Cell. Biochem. 255:2004;151-160.
208. Wang J.F., Bashir M., Engelsberg B.N., Witmer C., Rozmiarek H., Billings P.C. High mobility group proteins 1 and 2 recognize chromium-damaged DNA. Carcinogenesis. 18:1997;371-375.
209. Wang J.F., Engelsberg B.N., Johnson S.W., Witmer C., Merrick W.C., Rozmiarek H., Billings P.C. DNA binding activity of the mammalian translation elongation complex: recognition of chromium- and transplatin-damaged DNA. Arch. Toxicol. 71:1997;450-454.
210. Okada S., Suzuki M., Tsukada H., Ohba H. Alterations in the syntheses of RNA and DNA by chromium(III) in regenerating rat liver. Chem. Pharm. Bull. (Tokyo). 30:1982;3439-3441.
211. Ljungman M., Zhang F., Chen F., Rainbow A.J., McKay B.C. Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene. 18:1999;583-592.
212. Ljungman M., Paulsen M.T. The cyclin-dependent kinase inhibitor roscovitine inhibits RNA synthesis and triggers nuclear accumulation of p53 that is unmodified at Ser15 and Lys382. Mol. Pharmacol. 60:2001;785-789.
213. Lee K.B., Wang D., Lippard S.J., Sharp P.A. Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro. Proc. Natl. Acad. Sci. U.S.A. 99:2002;4239-4244.
214. Desai S.D., Zhang H., Rodriguez-Bauman A., Yang J.M., Wu X., Gounder M.K., Rubin E.H., Liu L.F. Transcription-dependent degradation of topoisomerase I-DNA covalent complexes. Mol. Cell Biol. 23:2003;2341-2350.
215. Carlisle D.L., Pritchard D.E., Singh J., Patierno S.R. Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol. Carcinog. 28:2000;111-118.
216. Blankenship L.J., Manning F.C., Orenstein J.M., Patierno S.R. Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol. Appl. Pharmacol. 126:1994;75-83.
217. Pritchard D.E., Ceryak S., Ha L., Fornsaglio J.L., Hartman S.K., O'Brien T.J., Patierno S.R. Mechanism of apoptosis and determination of cellular fate in chromium(VI)-exposed populations of telomerase-immortalized human fibroblasts. Cell Growth Differ. 12:2001;487-496.
218. Pritchard D.E., Singh J., Carlisle D.L., Patierno S.R. Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells. Carcinogenesis. 21:2000;2027-2033.
219. Bagchi D., Vuchetich P.J., Bagchi M., Hassoun E.A., Tran M.X., Tang L., Stohs S.J. Induction of oxidative stress by chronic administration of sodium dichromate (chromium VI) and cadmium chloride (cadmium II) to rats. Free Rad. Biol. Med. 22:1997;471-478.
220. Ueno S., Susa N., Furukawa Y., Aikawa K., Itagaki I. Cellular injury and lipid peroxidation induced by hexavalent chromium in isolated rat hepatocytes. Nippon Juigaku Zasshi. 51:1989;137-145.
221. Hojo Y., Satomi Y. In vivo nephrotoxicity induced in mice by chromium(VI). Involvement of glutathione and chromium(V). Biol. Trace Elem. Res. 31:1991;21-31.
222. Sugiyama M., Tsuzuki K. Effect of glutathione depletion on formation of paramagnetic chromium in Chinese hamster V-79 cells. FEBS Lett. 341:1994;273-276.
223. Cheng L., Sonntag D.M., de Boer J., Dixon K. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice. J. Environ. Pathol. Toxicol. Oncol. 19:2000;239-249.
224. Standeven A.M., Wetterhahn K.E. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats. Pharmacol. Toxicol. 68:1991;469-476.
225. Sitjes J., Ysern P., Barbe J., Llagostera M. Induction of ribonucleoside diphosphate reductase gene transcription by chemicals in Escherichia coli. Mutagenesis. 7:1992;47-49.
226. De Flora S., De Renzi G.P., Camoirano A., Astengo M., Basso C., Zanacchi P., Bennicelli C. Genotoxicity assay of oil dispersants in bacteria (mutation, differential lethality, SOS DNA-repair) and yeast (mitotic crossing-over). Mutat. Res. 158:1985;19-30.
227. Lantzsch H., Gebel T. Genotoxicity of selected metal compounds in the SOS chromotest. Mutat. Res. 389:1997;191-197.
228. Venier P., Montini R., Zordan M., Clonfero E., Paleologo M., Levis A.G. Induction of SOS response in Escherichia coli strain PQ37 by 16 chemical compounds and human urine extracts. Mutagenesis. 4:1989;51-57.
229. Llagostera M., Garrido S., Guerrero R., Barbe J. Induction of SOS genes of Escherichia coli by chromium compounds. Environ. Mutagen. 8:1986;571-577.
230. Helleday T., Nilsson R., Jenssen D. Arsenic(III) and heavy metal ions induce intrachromosomal homologous recombination in the hprt gene of V79 Chinese hamster cells. Environ. Mol. Mutagen. 35:2000;114-122.
231. Amrani S., Rizki M., Creus A., Marcos R. Genotoxic activity of different chromium compounds in larval cells of Drosophila melanogaster, as measured in the wing spot test. Environ. Mol. Mutagen. 34:1999;47-51.
232. Graf U., Heo O.S., Ramirez O.O. The genotoxicity of chromium(VI) oxide in the wing spot test of Drosophila melanogaster is over 90% due to mitotic recombination. Mutat. Res. 266:1992;197-203.
233. Katz A.J., Chiu A., Beaubier J., Shi X. Combining Drosophila melanogaster somatic-mutation-recombination and electron-spin-resonance- spectroscopy data to interpret epidemiologic observations on chromium carcinogenicity. Mol. Cell Biochem. 222:2001;61-68.
234. Rizki M., Amrani S., Creus A., Xamena N., Marcos R. Antigenotoxic properties of selenium: studies in the wing spot test in Drosophila. Environ. Mol. Mutagen. 37:2001;70-75.
235. Nestmann E.R., Matula T.I., Douglas G.R., Bora K.C., Kowbel D.J. Detection of the mutagenic activity of lead chromate using a battery of microbial tests. Mutat. Res. 66:1979;357-365.
236. Sung P., Trujillo K.M., Van Komen S. Recombination factors of Saccharomyces cerevisiae. Mutat. Res. 451:2000;257-275.
237. McHugh P.J., Sones W.R., Hartley J.A. Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae. Mol. Cell. Biol. 20:2000;3425-3433.
238. Sugiyama M., Wang X.W., Costa M. Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines. Cancer Res. 46:1986;4547-4551.
239. Vilcheck S.K., O'Brien T.J., Pritchard D.E., Ha L., Ceryak S., Fornsaglio J.L., Patierno S.R. Fanconi anemia complementation group A cells are hypersensitive to chromium(VI)-induced toxicity. Environ. Health Perspect. 110(Suppl. 5):2002;773-777.
240. Hodges N.J., Adam B., Lee A.J., Cross H.J., Chipman J.K. Induction of DNA-strand breaks in human peripheral blood lymphocytes and A549 lung cells by sodium dichromate: association with 8-oxo-2-deoxyguanosine formation and inter-individual variability. Mutagenesis. 16:2001;467-474.
241. Hodges N.J., Chipman J.K. Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells. Carcinogenesis. 23:2002;55-60.
242. Crothers D.M. Upsetting the balance of forces in DNA. Science. 266:1994;1819-1820.
243. E. Friedberg, G.C. Walker, W. Siede, DNA Repair and Mutagenesis, ASM Press, Washington, DC, 1995.
244. Brooks P.J., Wise D.S., Berry D.A., Kosmoski J.V., Smerdon M.J., Somers R.L., Mackie H., Spoonde A.Y., Ackerman E.J., Coleman K., Tarone R.E., Robbins J.H. The oxidative DNA lesion 8,5′-(S)-cyclo-2′-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem. 275:2000;22355-22362.
245. Cheng L., Liu S., Dixon K. Analysis of repair and mutagenesis of chromium-induced DNA damage in yeast, mammalian cells, and transgenic mice. Environ. Health Perspect. 106(Suppl. 4):1998;1027-1032.
246. Swanson R.L., Morey N.J., Doetsch P.W., Jinks-Robertson S. Overlapping specificities of base excision repair, nucleotide excision repair, recombination, and translesion synthesis pathways for DNA base damage in Saccharomyces cerevisiae. Mol. Cell Biol. 19:1999;2929-2935.
247. Patierno S.R., Banh D., Landolph J.R. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res. 48:1988;5280-5288.
248. Landolph J.R. Molecular mechanisms of transformation of C3H/10T1/2 C1 8 mouse embryo cells and diploid human fibroblasts by carcinogenic metal compounds. Environ. Health Perspect. 102(Suppl. 3):1994;119-125.
249. Seidman M.M., Dixon K., Razzaque A., Zagursky R.J., Berman M.L. A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells. Gene. 38:1985;233-237.
250. Trewick S.C., Henshaw T.F., Hausinger R.P., Lindahl T., Sedgwick B. Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. Nature. 419:2002;174-178.
251. Singh J., Pritchard D.E., Carlisle D.L., McLean J.A., Montaser A., Orenstein J.M., Patierno S.R. Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicol. Appl. Pharmacol. 161:1999;240-248.
252. Liu K., Husler J., Ye J., Leonard S.S., Cutler D., Chen F., Wang S., Zhang Z., Ding M., Wang L., Shi X. On the mechanism of Cr(VI)-induced carcinogenesis: dose dependence of uptake and cellular responses. Mol. Cell Biochem. 222:2001;221-229.
253. Ceryak S., Zingariello C., O'Brien T., Patierno S.R. Induction of pro-apoptotic and cell cycle-inhbiting gene in chromium(VI)-treated human lung fibroblasts: lack of effect of ERK. Mol. Cell. Biochem. 255:2004;139-149.
254. Flatt P.M., Polyak K., Tang L.J., Scatena C.D., Westfall M.D., Rubinstein L.A., Yu J., Kinzler K.W., Vogelstein B., Hill D.E., Pietenpol J.A. p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. Cancer Lett. 156:2000;63-72.
255. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
256. Ye J., Wang S., Leonard S.S., Sun Y., Butterworth L., Antonini J., Ding M., Rojanasakul Y., Vallyathan V., Castranova V., Shi X. Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. J. Biol. Chem. 274:1999;34974-34980.
257. Wang S., Shi X. Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation. Carcinogenesis. 22:2001;757-762.
258. Korsmeyer S.J., Gross A., Harada H., Zha J., Wang K., Yin X.M., Wei M., Zinkel S. Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules. Cold Spring Harb. Symp. Quant. Biol. 64:1999;343-350.
259. Karin M., Cao Y., Greten F.R., Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer. 2:2002;301-310.
260. Shumilla J.A., Wetterhahn K.E., Barchowsky A. Inhibition of NF-kappaB binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. Arch. Biochem. Biophys. 349:1998;356-362.
261. Shumilla J.A., Broderick R.J., Wang Y., Barchowsky A. Chromium(VI) inhibits the transcriptional activity of nuclear factor-kappaB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein. J. Biol. Chem. 274:1999;36207-36212.
262. Chen F., Bower J., Leonard S.S., Ding M., Lu Y., Rojanasakul Y., Kung H.F., Vallyathan V., Castranova V., Shi X. Protective roles of NF-kappaB for chromium(VI)-induced cytotoxicity is revealed by expression of IkappaB kinase-beta mutant. J. Biol. Chem. 277:2002;3342-3349.
263. Kaltreider R.C., Pesce C.A., Ihnat M.A., Lariviere J.P., Hamilton J.W. Differential effects of arsenic(III) and chromium(VI) on nuclear transcription factor binding. Mol. Carcinog. 25:1999;219-229.
264. Ballif B.A., Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ. 12:2001;397-408.
265. Thomas G. MAP kinase by any other name smells just as sweet. Cell. 68:1992;3-6.
266. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
267. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:2000;186-192.
268. Samet J.M., Graves L.M., Quay J., Dailey L.A., Devlin R.B., Ghio A.J., Wu W., Bromberg P.A., Reed W. Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am. J. Physiol. 275:1998;L551-L558.
269. Chuang S.M., Yang J.L. Comparison of roles of three mitogen-activated protein kinases induced by chromium(VI) and cadmium in non-small-cell lung carcinoma cells. Mol. Cell Biochem. 222:2001;85-95.
270. Chuang S.M., Liou G.Y., Yang J.L. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis. 21:2000;1491-1500.
271. Lawler S., Fleming Y., Goedert M., Cohen P. Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro. Curr. Biol. 8:1998;1387-1390.
272. Moriguchi T., Toyoshima F., Masuyama N., Hanafusa H., Gotoh Y., Nishida E. A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses. EMBO J. 16:1997;7045-7053.
273. Rivard N., Boucher M.J., Asselin C., L'Allemain G. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells. Am. J. Physiol. 277:1999;C652-C664.
274. Tang D., Wu D., Hirao A., Lahti J.M., Liu L., Mazza B., Kidd V.J., Mak T.W., Ingram A.J. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem. 277:2002;12710-12717.
275. Persons D.L., Yazlovitskaya E.M., Cui W., Pelling J.C. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin. Cancer Res. 5:1999;1007-1014.
276. Buckley S., Driscoll B., Barsky L., Weinberg K., Anderson K., Warburton D. ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. Am. J. Physiol. 277:1999;L159-L166.
277. DeHaan R.D., Yazlovitskaya E.M., Persons D.L. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase. Cancer Chemother. Pharmacol. 48:2001;383-388.
278. Greulich H., Erikson R.L. An analysis of Mek1 signaling in cell proliferation and transformation. J. Biol. Chem. 273:1998;13280-13288.
279. Moelling K., Schad K., Bosse M., Zimmermann S., Schweneker M. Regulation of Raf-Akt Cross-talk. J. Biol. Chem. 277:2002;31099-31106.
280. Murphy L.O., Smith S., Chen R.H., Fingar D.C., Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell. Biol. 4:2002;556-564.
281. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421:2003;499-506.
282. Montrel M.M., Shabarchina L.I., Pletneva T.V., Ershov Iu A. IR-spectroscopic study of the interaction of chromium salts with native DNA. Biofizika. 38:1993;636-643.
283. Bagchi D., Hassoun E.A., Bagchi M., Muldoon D.F., Stohs S.J. Oxidative stress induced by chronic administration of sodium dichromate [Cr(VI)] to rats. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 110:1995;281-287.
284. Bagchi D., Hassoun E.A., Bagchi M., Stohs S.J. Chromium-induced excretion of urinary lipid metabolites, DNA damage, nitric oxide production, and generation of reactive oxygen species in Sprague-Dawley rats. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 110:1995;177-187.
285. Blasiak J., Trzeciak A., Malecka-Panas E., Drzewoski J., Iwanienko T., Szumiel I., Wojewodzka M. DNA damage and repair in human lymphocytes and gastric mucosa cells exposed to chromium and curcumin. Teratog. Carcinog. Mutagen. 19:1999;19-31.
286. Cupo D.Y., Wetterhahn K.E. Modification of chromium(VI)-induced DNA damage by glutathione and cytochromes P-450 in chicken embryo hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 82:1985;6755-6759.
287. da Cruz Fresco P., Shacker F., Kortenkamp A. The reductive conversion of chromium(VI) by ascorbate gives rise to apurinic/apyrimidinic sites in isolated DNA. Chem. Res. Toxicol. 8:1995;884-890.
288. Flores A., Perez J.M. Cytotoxicity, apoptosis, and in vitro DNA damage induced by potassium chromate. Toxicol. Appl. Pharmacol. 161:1999;75-81.
289. Gao M., Binks S.P., Chipman J.K., Levy L.S., Braithwaite R.A., Brown S.S. Induction of DNA strand breaks in peripheral lymphocytes by soluble chromium compounds. Hum. Exp. Toxicol. 11:1992;77-82.
290. Gao M., Binks S.P., Chipman J.K., Levy L.S. Hexavalent chromium produces DNA strand breakage but not unscheduled DNA synthesis at sub-cytotoxic concentrations in hepatocytes. Toxicology. 77:1993;171-180.
291. Gao M., Levy L.S., Faux S.P., Aw T.C., Braithwaite R.A., Brown S.S. Use of molecular epidemiological techniques in a pilot study on workers exposed to chromium. Occup. Environ. Med. 51:1994;663-668.
292. Hassoun E.A., Stohs S.J. Chromium-induced production of reactive oxygen species, DNA single-strand breaks, nitric oxide production, and lactate dehydrogenase leakage in J774A.1 cell cultures. J. Biochem. Toxicol. 10:1995;315-321.
293. Kortenkamp A., Ozolins Z., Beyersmann D., O'Brien P. Generation of PM2 DNA breaks in the course of reduction of chromium(VI) by glutathione. Mutat. Res. 216:1989;19-26.
294. Lee R., Kim G.B., Maruya K.A., Steinert S.A., Oshima Y. DNA strand breaks (Comet assay) and embryo development effects in grass shrimp (Palaemonetes pugio) embryos after exposure to genotoxicants. Mar. Environ. Res. 50:2000;553-557.
295. Levina A., Barr-David G., Codd R., Lay P.A., Dixon N.E., Hammershoi A., Hendry P. In vitro plasmid DNA cleavage by chromium(V) and -(IV) 2-hydroxycarboxylato complexes. Chem. Res. Toxicol. 12:1999;371-381.
296. Liu X., Liu S. Plasmid DNA breakage caused by reaction of intracellular redox compound with potassium dichromate. Zhonghua Yu Fang Yi Xue Za Zhi. 33:1999;354-356.
297. Lloyd D.R., Carmichael P.L., Phillips D.H. Comparison of the formation of 8-hydroxy-2′-deoxyguanosine and single- and double-strand breaks in DNA mediated by fenton reactions. Chem. Res. Toxicol. 11:1998;420-427.
298. Luo H., Lu Y., Mao Y., Shi X., Dalal N.S. Role of chromium(IV) in the chromium(VI)-related free radical formation, dG hydroxylation, and DNA damage. J. Inorg. Biochem. 64:1996;25-35.
299. Luo H., Lu Y., Shi X., Mao Y., Dalal N.S. Chromium(IV)-mediated fenton-like reaction causes DNA damage: implication to genotoxicity of chromate. Ann. Clin. Lab. Sci. 26:1996;185-191.
300. Merzenich H., Hartwig A., Ahrens W., Beyersmann D., Schlepegrell R., Scholze M., Timm J., Jockel K.H. Biomonitoring on carcinogenic metals and oxidative DNA damage in a cross-sectional study. Cancer Epidemiol. Biomarkers Prev. 10:2001;515-522.
301. Shi X., Ding M., Ye J., Wang S., Leonard S.S., Zang L., Castranova V., Vallyathan V., Chiu A., Dalal N., Liu K. Cr(IV) causes activation of nuclear transcription factor-kappaB. J. Inorg. Biochem. 75:1999;37-44.
302. Stearns D.M., Wetterhahn K.E. Intermediates produced in the reaction of chromium(VI) with dehydroascorbate cause single-strand breaks in plasmid DNA. Chem. Res. Toxicol. 10:1997;271-278.
303. Sugden K.D. Formation of modified cleavage termini from the reaction of chromium(V) with DNA. J. Inorg. Biochem. 77:1999;177-183.
304. Sugden K.D., Geer R.D., Rogers S.J. Oxygen radical-mediated DNA damage by redox-active Cr(III) complexes. Biochemistry. 31:1992;11626-11631.
305. Sugiyama M., Ando A., Ogura R. Vitamin B2-enhancement of sodium chromate (VI)-induced DNA single strand breaks: ESR study of the action of Vitamin B2. Biochem. Biophys. Res. Commun. 159:1989;1080-1085.
306. Sugiyama M. Effects of vitamins on chromium(VI)-induced damage. Environ. Health. Perspect. 92:1991;63-70.
307. Tsuzuki K., Sugiyama M., Haramaki N. DNA single-strand breaks and cytotoxicity induced by chromate(VI), cadmium(II), and mercury(II) in hydrogen peroxide-resistant cell lines. Environ. Health Perspect. 102(Suppl. 3):1994;341-342.
308. Wozniak K. Molecular effects of chromium compound activity. Postepy. Hig. Med. Dosw. 50:1996;383-394.
309. 4 in synchronous and asynchronous cultured mammalian cells. Mol. Pharmacol. 29:1986;606-613.
310. Sugiyama M. Effects of Vitamin E and Vitamin B2 on chromate-induced DNA lesions. Biol. Trace Elem. Res. 21:1989;399-404.
311. Costa M., Zhitkovich A., Gargas M., Paustenbach D., Finley B., Kuykendall J., Billings R., Carlson T.J., Wetterhahn K., Xu J., Patierno S., Bogdanffy M. Interlaboratory validation of a new assay for DNA-protein crosslinks. Mutat. Res. 369:1996;13-21.
312. Costa M., Zhitkovich A., Toniolo P. DNA-protein cross-links in welders: molecular implications. Cancer Res. 53:1993;460-463.
313. Costa M., Zhitkovich A., Taioli E., Toniolo P. Preliminary report on a simple new assay for DNA-protein cross-links as a biomarker of exposures experienced by welders. J. Toxicol. Environ. Health. 40:1993;217-222.
314. Costa M., Zhitkovich A., Toniolo P., Taioli E., Popov T., Lukanova A. Monitoring human lymphocytic DNA-protein cross-links as biomarkers of biologically active doses of chromate. Environ. Health Perspect. 104(Suppl 5):1996;917-919.
315. Mattagajasingh S.N., Misra H.P. Analysis of EDTA-chelatable proteins from DNA-protein crosslinks induced by a carcinogenic chromium(VI) in cultured intact human cells. Mol. Cell Biochem. 199:1999;149-162.
316. Medeiros M.G., Rodrigues A.S., Batoreu M.C., Laires A., Rueff J., Zhitkovich A. Elevated levels of DNA-protein crosslinks and micronuclei in peripheral lymphocytes of tannery workers exposed to trivalent chromium. Mutagenesis. 18:2003;19-24.
317. Merk O., Speit G. Detection of crosslinks with the Comet assay in relationship to genotoxicity and cytotoxicity. Environ. Mol. Mutagen. 33:1999;167-172.
318. Merk O., Reiser K., Speit G. Analysis of chromate-induced DNA-protein crosslinks with the comet assay. Mutat. Res. 471:2000;71-80.
319. Miller C.A. III, Costa M. Immunodetection of DNA-protein crosslinks by slot blotting. Mutat. Res. 234:1990;97-106.
320. Taioli E., Zhitkovich A., Kinney P., Udasin I., Toniolo P., Costa M. Increased DNA-protein crosslinks in lymphocytes of residents living in chromium-contaminated areas. Biol. Trace Elem. Res. 50:1995;175-180.
321. Wedrychowski A., Schmidt W.N., Hnilica L.S. DNA-protein crosslinking by heavy metals in Novikoff hepatoma. Arch. Biochem. Biophys. 251:1986;397-402.
322. Xu J., Wise J.P., Patierno S.R. DNA damage induced by carcinogenic lead chromate particles in cultured mammalian cells. Mutat. Res. 280:1992;129-136.
323. Zhitkovich A., Voitkun V., Kluz T., Costa M. Utilization of DNA-protein cross-links as a biomarker of chromium exposure. Environ. Health Perspect. 106(Suppl. 4):1998;969-974.
324. Moghaddas S., Gelerinter E., Bose R.N. Mechanisms of formation and decomposition of hypervalent chromium metabolites in the glutathione- chromium(VI) reaction. J. Inorg. Biochem. 57:1995;135-146.
325. Shi X.G., Dalal N.S. On the hydroxyl radical formation in the reaction between hydrogen peroxide and biologically generated chromium(V) species. Arch. Biochem. Biophys. 277:1990;342-350.
326. Izzotti A., Bagnasco M., Camoirano A., Orlando M., De Flora S. DNA fragmentation, DNA-protein crosslinks, postlabeled nucleotidic modifications, and 8-hydroxy-2′-deoxyguanosine in the lung but not in the liver of rats receiving intratracheal instillations of chromium(VI). Chemoprevention by oral N-acetylcysteine. Mutat. Res. 400:1998;233-244.
327. Faux S.P., Gao M., Chipman J.K., Levy L.S. Production of 8-hydroxydeoxyguanosine in isolated DNA by chromium(VI) and chromium(V). Carcinogenesis. 13:1992;1667-1669.
328. Shi X., Mao Y. 8-Hydroxy-2′-deoxyguanosine formation and DNA damage induced by sulfur trioxide anion radicals. Biochem. Biophys. Res. Commun. 205:1994;141-147.
329. Yuann J.M., Liu K.J., Hamilton J.W., Wetterhahn K.E. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2′-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI). Carcinogenesis. 20:1999;1267-1275.
330. Gulanowski B., Cieslak-Golonka M., Szyba K., Urban J. In vitro studies on the DNA impairments induced by Cr(III) complexes with cellular reductants. Biometals. 7:1994;177-184.